mobile  Test Directory

DRUGS OF ABUSE 700 RFLX

Test Code
DA700
 
This test may reflex to additional tests depending upon the results of this test. An additional fee will be added if the reflex test is necessary.
This test is a lab developed test. For further information, see the Compliance Remarks section below.
SPECIMEN REQUIREMENTS
Container Type
Random urine
Supply Item Number
1387
Specimen Type
Random urine
Preferred Volume
30 mL
Emergency Minimum Volume
15 mL
Collection Procedure
Collect a random urine in a leakproof plastic urine container.
Store and Transport
Ambient (room temperature)
Stability
Room Temp 10 days  Refrigerated 1 month  
Reference Laboratory
PAML
Reference Lab Test Code
LCA code 910998
CPT Codes
80307
Interface Order Code
80100.Z187
Billing Code
DA700
Test Schedule
Mon-Sat
Turnaround Time
1-3 days
Method
Enzyme Immunoassay
Reference Ranges
TitleDescriptorRangesUnits
Urine CreatinineNormal> 19mg/dL
Urine pHNormal4.5-9.0
Urine Specific GravityNormal1.003-1.020
Cannabinoid ScreenNegative< 50ng/mL
Amphetamines ScreenNegative< 500ng/mL
Cocaine (BEG) ScreenNegative< 150ng/mL
Opiates ScreenNegative< 300ng/mL
Oxycodone ScreenNegative< 100ng/mL
6MAM ScreenNegative< 10ng/mL
Compliance Remarks
This test was developed and its performance characteristics determined by PAML. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test. However, FDA approval or clearance is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. PAML is authorized under Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing.
Notes
The DA700 offers a qualitative screen and quantitative confirmation for the licit and illicit drugs listed above.
Reflex Testing
Reflex ConditionReflex Test NameReflex CPT codesReflex Billing codes
Cannabinoid Screen PositiveMSTHC80349BMSTHC
Cocaine Screen PositiveMSCOC80353BMSCOC
Amphetamines Screen PositiveMSAPX80324, 80359BMSAPX
Opiates Screen PositiveLCOP980356, 80365, 80361BLCOP9
Oxycodone Screen PositiveLCOP980356, 80365, 80361BLCOP9
6MAM Screen PositiveLCOP980356, 80365, 80361BLCOP9

Interface Codes
typeorder codetest descriptionresult coderesult descriptionunitsdecimal placesloinc code
o80100.Z187Drugs of Abuse 700
r80100.Z187Drugs of Abuse 70080100.Z163MDEA (GCMS)ng/mL 27085-0
r80100.Z187Drugs of Abuse 70080100.Z168Noroxycodone (LCMSMS)ng/mL 61423-0
r80100.Z187Drugs of Abuse 70080100.Z169Norhydrocodone (LCMSMS)ng/mL 61420-6
r80100.Z187Drugs of Abuse 70080101.Z25Opiate Screenng/mL 8220-6
r80100.Z187Drugs of Abuse 70080101.Z31Amphet/Methamphet Screenng/mL 43983-6
r80100.Z187Drugs of Abuse 70080101.Z55MDMA (GCMS)ng/mL018358-2
r80100.Z187Drugs of Abuse 70080101.Z56MDA (GCMS)ng/mL 20545-0
r80100.Z187Drugs of Abuse 70080101.Z6Cannabinoid Screenng/mL 70145-8
r80100.Z187Drugs of Abuse 70080101.Z656 MAM Screenng/mL019321-9
r80100.Z187Drugs of Abuse 70080101.Z66Oxycodone Screenng/mL019642-8
r80100.Z187Drugs of Abuse 70080101.Z8Cocaine Screenng/mL 43984-4
r80100.Z187Drugs of Abuse 70080102.Z1096 MAM (Heroin Metabolite) (LCMSMS)ng/mL 19593-3
r80100.Z187Drugs of Abuse 70080102.Z11Amphetamine (GCMS)ng/mL 20410-7
r80100.Z187Drugs of Abuse 70080102.Z12Methamphetamine (GCMS)ng/mL 16235-4
r80100.Z187Drugs of Abuse 70080102.Z26Cocaine Metab (GCMS)ng/mL 53743-1
r80100.Z187Drugs of Abuse 70080102.Z38Carboxy-THC (GCMS)ng/mL 20521-1
r80100.Z187Drugs of Abuse 70080102.Z81Morphine (LCMSMS)ng/ml 16251-1
r80100.Z187Drugs of Abuse 70080102.Z82Oxymorphone (LCMSMS)ng/ml 17395-5
r80100.Z187Drugs of Abuse 70080102.Z83Hydromorphone (LCMSMS)ng/ml 16998-7
r80100.Z187Drugs of Abuse 70080102.Z84Codeine (LCMSMS)ng/ml 16250-3
r80100.Z187Drugs of Abuse 70080102.Z85Oxycodone (LCMSMS)ng/ml 16249-5
r80100.Z187Drugs of Abuse 70080102.Z86Hydrocodone (LCMSMS)ng/ml 16252-9
r80100.Z187Drugs of Abuse 70081000.Z15Toxicology Specific Gravity 35811-5
r80100.Z187Drugs of Abuse 70082570.Z15Tox Creatininemg/dL02161-8
r80100.Z187Drugs of Abuse 70083986.Z9Toxicology pH  2756-5

v1.0|1101|3|1|0


Questions/Comments